{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T00:45:23Z","timestamp":1794271523416,"version":"4.9.0"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,10]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Combination antiretroviral drug regimens are increasingly preferred for neonatal postexposure prophylaxis (PEP) among HIV-exposed infants with high-risk of transmission. We evaluated the adverse events associated with the use of zidovudine (ZDV)\/lamivudine (3TC)\/nevirapine (NVP) for neonatal PEP during the first 6 weeks of life.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>A prospective cohort of non-breast-fed HIV-exposed infants was conducted at 5 clinical sites in Thailand. Study population included 100 high-risk HIV-exposed infants (maternal HIV RNA &gt; 50 copies\/mL prior to delivery or received antiretroviral therapy less than 12 weeks) and 100 low-risk HIV-exposed neonates. High-risk infants received ZDV\/3TC\/NVP for 6 weeks whereas low-risk HIV-exposed neonates received a 4-week regimen of ZDV. Complete blood count, aspartate transaminase and alanine transaminase were assessed at birth, 1, 2 and 4 months of life.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>From October 2015 to November 2017, 200 infants were enrolled, of which 18.5% had low birth weight &lt; 2500\u2009g. The proportion of infants with anemia grade 2 or higher at 1 and 2 months of life between ZDV\/3TC\/NVP and ZDV prophylaxis was 48.5% vs 32.3% (<jats:italic toggle=\"yes\">P<\/jats:italic>=0.02); nevertheless, severe anemia (grade 3) was not significantly different; 9.2% vs 10.2% (<jats:italic toggle=\"yes\">P<\/jats:italic>=0.81), respectively. At 1 month old, infants on ZDV\/3TC\/NVP prophylaxis had significantly higher grade 2 anemia versus infants on ZDV alone (33.0% vs 13.4%; <jats:italic toggle=\"yes\">P<\/jats:italic>=0.001); however, no difference was observed at 2 months old. No differences in neutropenia or hepatotoxicity between infant prophylactic regimens were observed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>Triple antiretroviral neonatal PEP with ZDV\/3TC\/NVP for 6 weeks in high-risk HIV-exposed infants did not significantly increase the risk of short-term toxicity compared with ZDV-monotherapy prophylaxis.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/inf.0000000000002426","type":"journal-article","created":{"date-parts":[[2019,7,31]],"date-time":"2019-07-31T13:49:48Z","timestamp":1564580988000},"page":"1045-1050","source":"Crossref","is-referenced-by-count":8,"title":["Safety of 6-week Neonatal Triple-combination Antiretroviral Postexposure Prophylaxis in High-risk HIV-exposed Infants"],"prefix":"10.1097","volume":"38","author":[{"given":"Suvaporn","family":"Anugulruengkitt","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Faculty of Medicine"},{"name":"Center of Excellence for Pediatric Infectious Diseases and Vaccines, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piyarat","family":"Suntarattiwong","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Faculty of Medicine, Queen Sirikit National Institute of Child Health, Bangkok, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pradthana","family":"Ounchanum","sequence":"additional","affiliation":[{"name":"Chiang Rai Prachanukroh Hospital, Chiang Rai, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ussanee","family":"Srirompotong","sequence":"additional","affiliation":[{"name":"Khon Kaen Hospital, Khon Kaen, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Watsamon","family":"Jantarabenjakul","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Faculty of Medicine"},{"name":"Center of Excellence for Pediatric Infectious Diseases and Vaccines, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiratchaya","family":"Sophonphan","sequence":"additional","affiliation":[{"name":"The HIV Netherlands Australia Thailand Research Collaboration (HIV-NAT), the Thai Red Cross AIDS Research Centre, Bangkok, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunti","family":"Punnahitanon","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Faculty of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chitsanu","family":"Pancharoen","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Faculty of Medicine"},{"name":"Center of Excellence for Pediatric Infectious Diseases and Vaccines, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim R.","family":"Cressey","sequence":"additional","affiliation":[{"name":"Program for HIV Prevention and Treatment, Department of Medical Technology, Faculty of Associated Medical Sciences (PHPT\/IRD), Chiang Mai University, Chiang Mai, Thailand"},{"name":"Harvard T.H. Chan School of Public Health, Boston, Massachusetts"},{"name":"Department of Molecular and Clinical Pharmacology, University of Liverpool, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kulkanya","family":"Chokephaibulkit","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thanyawee","family":"Puthanakit","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Faculty of Medicine"},{"name":"Center of Excellence for Pediatric Infectious Diseases and Vaccines, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20240429","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1097\/QAD.0b013e32835cffb1","article-title":"Use of combination neonatal prophylaxis for the prevention of mother-to-child transmission of HIV infection in European high-risk infants.","volume":"27","author":"Chiappini","year":"2013","journal-title":"AIDS"},{"key":"R5-20240429","doi-asserted-by":"crossref","first-page":"562","DOI":"10.15585\/mmwr.mm6522a2","article-title":"Elimination of mother-to-child transmission of HIV - Thailand.","volume":"65","author":"Lolekha","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R7-20240429","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1086\/518284","article-title":"Time to undetectable viral load after highly active antiretroviral therapy initiation among HIV-infected pregnant women.","volume":"44","author":"Patel","year":"2007","journal-title":"Clin Infect Dis"},{"key":"R8-20240429","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1097\/QAD.0000000000000212","article-title":"Earlier initiation of ART and further decline in mother-to-child HIV transmission rates, 2000-2011.","volume":"28","author":"Townsend","year":"2014","journal-title":"AIDS"},{"key":"R9-20240429","first-page":"145","article-title":"Thai national guidelines for the prevention of mother-to-child transmission of human immunodeficiency virus 2017.","volume":"11","author":"Lolekha","year":"2017","journal-title":"Asian Biomed (Res Rev News)"},{"key":"R10-20240429","doi-asserted-by":"crossref","first-page":"e0127062","DOI":"10.1371\/journal.pone.0127062","article-title":"Serious adverse events are uncommon with combination neonatal antiretroviral prophylaxis: a retrospective case review.","volume":"10","author":"Smith","year":"2015","journal-title":"PLoS One"},{"key":"R11-20240429","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1056\/NEJMoa1108275","article-title":"Three postpartum antiretroviral regimens to prevent intrapartum HIV infection.","volume":"366","author":"Nielsen-Saines","year":"2012","journal-title":"N Engl J Med"},{"key":"R13-20240429","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1089\/aid.2010.0034","article-title":"Hematological safety of perinatal exposure to zidovudine in uninfected infants born to HIV type 1-infected women in Thailand.","volume":"26","author":"Briand","year":"2010","journal-title":"AIDS Res Hum Retroviruses"},{"key":"R14-20240429","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/S0022-3476(71)80076-8","article-title":"Physiologic anemia of the newborn infant.","volume":"79","author":"O\u2019Brien","year":"1971","journal-title":"J Pediatr"},{"key":"R15-20240429","doi-asserted-by":"crossref","first-page":"20520","DOI":"10.7448\/IAS.19.1.20520","article-title":"Safety of combination antiretroviral prophylaxis in high-risk HIV-exposed newborns: a retrospective review of the Canadian experience.","volume":"19","author":"Kakkar","year":"2016","journal-title":"J Int AIDS Soc"},{"issue":"pt 8","key":"R16-20240429","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1099\/jmm.0.47782-0","article-title":"Lamivudine-induced red cell aplasia.","volume":"57","author":"John","year":"2008","journal-title":"J Med Microbiol"},{"key":"R17-20240429","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1038\/ejcn.2016.255","article-title":"Impact of maternal, antenatal and birth-associated factors on iron stores at birth: data from a prospective maternal-infant birth cohort.","volume":"71","author":"McCarthy","year":"2017","journal-title":"Eur J Clin Nutr"},{"key":"R18-20240429","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.placenta.2013.10.011","article-title":"Impact of cesarean section on placental transfusion and iron-related hematological indices in term neonates: a systematic review and meta-analysis.","volume":"35","author":"Zhou","year":"2014","journal-title":"Placenta"},{"key":"R19-20240429","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1097\/QAI.0b013e31820bd2b6","article-title":"Increased risk of severe infant anemia after exposure to maternal HAART, Botswana.","volume":"56","author":"Dryden-Peterson","year":"2011","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R20-20240429","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S0140-6736(99)80008-7","article-title":"Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial.","volume":"354","author":"Guay","year":"1999","journal-title":"Lancet"},{"key":"R22-20240429","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2165\/00002018-200932020-00007","article-title":"Hepatotoxicity associated with long- versus short-course HIV-prophylactic nevirapine use: a systematic review and meta-analysis from the Research on Adverse Drug events And Reports (RADAR) project.","volume":"32","author":"McKoy","year":"2009","journal-title":"Drug Saf"},{"key":"R23-20240429","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1056\/NEJMoa0911486","article-title":"Maternal or infant antiretroviral drugs to reduce HIV-1 transmission.","volume":"362","author":"Chasela","year":"2010","journal-title":"N Engl J Med"},{"key":"R24-20240429","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1097\/QAI.0000000000001291","article-title":"Nevirapine pharmacokinetics and safety in neonates receiving combination antiretroviral therapy for prevention of vertical HIV transmission.","volume":"74","author":"Lau","year":"2017","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R26-20240429","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1080\/17512433.2018.1393331","article-title":"Prevention and treatment of HIV infection in neonates: evidence base for existing WHO dosing recommendations and implementation considerations.","volume":"11","author":"Clarke","year":"2018","journal-title":"Expert Rev Clin Pharmacol"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000002426","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,29]],"date-time":"2024-04-29T18:11:06Z","timestamp":1714414266000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000002426"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":19,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000002426","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]}}}